Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial
ContributorsMehilli, Julinda; Pache, Jürgen; Abdel-Wahab, Mohamed; Schulz, Stefanie; Byrne, Robert A; Tiroch, Klaus; Hausleiter, Jörg; Seyfarth, Melchior; Ott, Ilka; Ibrahim, Tareq; Fusaro, Massimiliano; Laugwitz, Karl-Ludwig; Massberg, Steffen; Neumann, Franz-Josef; Richardt, Gert; Schömig, Albert; Kastrati, Adnan; ISAR-CABG investigators
CollaboratorsDirlewanger, Mijam
Published inLancet, vol. 378, no. 9796, p. 1071-1078
Publication date2011
Abstract
Keywords
- Absorbable Implants
- Aged
- Angioplasty, Balloon, Coronary
- Coronary Artery Bypass
- Drug-Eluting Stents/adverse effects
- Female
- Graft Occlusion, Vascular/surgery
- Humans
- Male
- Metals
- Paclitaxel
- Polymers
- Saphenous Vein/pathology/surgery/transplantation
- Sirolimus
- Stents/adverse effects
Affiliation entities
Citation (ISO format)
MEHILLI, Julinda et al. Drug-eluting versus bare-metal stents in saphenous vein graft lesions (ISAR-CABG): a randomised controlled superiority trial. In: Lancet, 2011, vol. 378, n° 9796, p. 1071–1078. doi: 10.1016/S0140-6736(11)61255-5
Main files (1)
Article (Published version)
Identifiers
- PID : unige:25780
- DOI : 10.1016/S0140-6736(11)61255-5
- PMID : 21872918
Journal ISSN0140-6736
